National adoption of neoadjuvant chemotherapy: paradigm shift in the treatment of pancreatic cancer-Reference-Cited by-同舟云学术

National adoption of neoadjuvant chemotherapy: paradigm shift in the treatment of pancreatic cancer

Published:2023-11 Issue:11 Volume:25 Page:1323-1328
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Nassour Ibrahim^ORCID,Parrish Austin^ORCID,Baptist Lucy,Voskamp Sarah,Handoo Komal,Rogers Sherise,Fabregas Jesus^ORCID,George Thomas^ORCID,Hitchcock Kathryn^ORCID,Paniccia Alessandro^ORCID,Hughes Steven

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference17 articles.

1. Cancer Statistics, 2022;Siegel;Ca Cancer J Clin,2022

2. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the conko-001 randomized trial;Oettle;Jama,2013

3. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer;Neoptolemos;New Engl J Medicine,2004

4. Ampullary cancer espac-3 (v2) trial: a multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater;Neoptolemos;J Clin Oncol,2016

5. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the espac-3 periampullary cancer randomized trial;Neoptolemos;Jama,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disparities in neoadjuvant chemotherapy for pancreatic adenocarcinoma with vascular involvement;Surgery Open Science;2024-08

2. Tumor-intrinsic and Cancer-associated Fibroblast Subtypes Independently Predict Outcomes in Pancreatic Cancer;Annals of Surgery;2024-06-18

3. Fragmented care in localized pancreatic cancer: Is commission on cancer accreditation associated with improved overall survival?;Surgery;2024-03

4. Neoadjuvant and Adjuvant Chemotherapy for Pancreatic Adenocarcinoma: Literature Review and Our Experience of NAC-GS;Cancers;2024-02-23

5. ASO Practice Guidelines Series: Management of Resectable, Borderline Resectable, and Locally Advanced Pancreas Cancer;Annals of Surgical Oncology;2023-11-19